CCX559 is a potent orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity.

被引：0

作者：

Li, Chris ^{[1
]}

Vilalta, Marta ^{[1
]}

Ertl, Linda S. ^{[1
]}

Wang, Yu ^{[1
]}

Zeng, Yibin ^{[1
]}

Fan, Pingchen ^{[1
]}

Lange, Christopher ^{[1
]}

McMurtrie, Darren ^{[1
]}

Yang, Ju ^{[1
]}

Lui, Rebecca ^{[1
]}

Scamp, Ryan ^{[1
]}

Chhina, Vicky ^{[1
]}

Kumamoto, Alice ^{[1
]}

Ong, Ryan ^{[1
]}

Dang, Ton ^{[1
]}

Easterday, Ashton ^{[1
]}

Zhao, Niky ^{[1
]}

Liu, Shirley ^{[1
]}

Singh, Rajinder ^{[1
]}

Charo, Israel ^{[1
]}

Sullivan, Kathleen ^{[1
]}

Schall, Thomas J. ^{[1
]}

Zhang, Penglie ^{[1
]}

机构：

[1] ChemoCentryx, Mountain View, CA USA

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1274

引用

页数：1

共 50 条

[1] CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity
Sullivan, Kathleen M. C.
Vilalta, Marta
Ertl, Linda S.
Wang, Yu
Dunlap, Carolyn
Ebsworth, Karen
Zhao, Bin N.
Li, Shijie
Zeng, Yibin
Miao, Zhenhua
Fan, Pingchen
Mali, Venkat
Lange, Christopher
McMurtrie, Darren
Yang, Ju
Lui, Rebecca
Scamp, Ryan
Chhina, Vicky
Kumamoto, Alice
Yau, Simon
Dang, Ton
Easterday, Ashton
Liu, Shirley
Miao, Shichang
Charo, Israel
Schall, Thomas J.
Zhang, Penglie
PLOS ONE, 2023, 18 (06):
[2] CCX559, an orally administered small molecule PD-L1 inhibitor for the treatment of solid tumors
Sullivan, Kathleen M.
Miao, Shichang
Yue, Huibin
Zhao, Niky
Li, Chris
Tai, Ezra
Ebsworth, Karen
Rico, Gonzalo Tapia
De Souza, Paul
Schall, Tom
Zhang, Penglie
CANCER RESEARCH, 2022, 82 (12)
[3] Preliminary data from an ongoing phase 1 dose-escalation study of CCX559, an orally administered small molecule PD-L1 inhibitor, in patients with advanced solid tumors
Tapia, Gonzalo
Lundy, Joanne
Richardson, Gary Edward
Zhao, Niky
Ebsworth, Karen
Yue, Huibin
Miao, Shichang
Degoma, Emil
Jain, Rita
Schall, Thomas J.
Sullivan, Kathleen
Zhang, Penglie
De Souza, Paul L.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[4] RESULTS FROM AN ONGOING OPEN-LABEL, MULTICENTER, PHASE 1 TRIAL OF CCX559, AN ORALLY ADMINISTERED SMALL MOLECULE PD-L1 INHIBITOR, IN PATIENTS WITH ADVANCED SOLID TUMORS
Tapia-Rico, Gonzalo
Lundy, Joanne
Richardson, Gary
Zhao, Niky
Ebsworth, Karen
Yue, Huibin
Miao, Shichiang
deGoma, Emil
Jain, Rita
Schall, Thomas
Sullivan, Kathleen
Zhang, Penglie
de Souza, Paul
deGoma, Emil
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A800 - A800
[5] THE SMALL MOLECULE PD-L1 INHIBITOR CCX559 PREFERENTIALLY ACCUMULATES IN TUMORS, RESULTING IN DEPLETION OF CELL-SURFACE PD-L1 IN A MURINE PRECLINICAL MODEL
Sullivan, Kathleen
Ertl, Linda
Miao, Zhenhua
Fan, Pingchen
Zeng, Yibin
Dunlap, Carolyn
Ebsworth, Karen
Gupta, Suprit
Li, Shijie Chris
Dang, Ton
Miao, Shichang
Charo, Israel
Schall, Thomas
Zhang, Penglie
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A520 - A520
[6] Targeting the intrinsic signaling of PD-L1 in human monocytes by a novel PD-L1 antibody to promote anti-tumor immunity.
Hsu, Michelle A.
Liu, Xin
Barham, Whitney
Hirdler, Jacob
Mao, Zhiming
Lucien, Fabrice
Dong, Haidong
JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
[7] Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
Poggio, Mauro
Hu, Tianyi
Pai, Chien-Chun
Chu, Brandon
Belair, Cassandra D.
Chang, Anthony
Montabana, Elizabeth
Lang, Ursula E.
Fu, Qi
Fong, Lawrence
Blelloch, Robert
CELL, 2019, 177 (02) : 414 - +
[8] Anti-tumor effect of orally available small molecule PD-L1 inhibitors in a murine model of colon adenocarcinoma
Li, Shijie
Vilalta, Marta
Ertl, Linda S.
Wang, Yu
Zeng, Yibin
Fan, Pingchen
Lange, Christopher
McMurtrie, Darren
Yang, Ju
Lui, Rebecca
Ong, Ryan
Chhina, Vicky
Kumamoto, Alice
Yau, Simon
Dang, Ton
Easterday, Ashton
Liu, Shirley
Singh, Rajinder
Charo, Israel
Schall, Thomas J.
Zhang, Penglie
CANCER RESEARCH, 2020, 80 (16)
[9] Targeting glycosylated PD-1 induces potent anti-tumor immunity
Wang, Yuhan
Sun, Linlin
Yang, Riyao
Liu, Jielin
Qiu, Yufan
Hsu, Jennifer L.
Cha, Jong-ho
Chan, Li-Chuan
Hsu, Jung-Mao
Lee, Heng-Huan
Lai, Yun-Ju
Khoo, Kay-Hooi
Chung, Ezra M.
Li, Chia-Wei
Kim, Yong-Soo
Park, Andrew H.
Yang, Yi
Yoo, Stephen S.
Hung, Mien-Chie
CANCER RESEARCH, 2020, 80 (16)
[10] Discovery of novel potent and orally bioavailable small-molecule inhibitors of ENPP1 to stabilize cGAMP and ATP in the tumor microenvironment and boost anti-tumor immunity.
Versele, Matthias
Garcia, Javier del Pino
Vandecaetsbeek, Ilse
Castermans, Karolien
Kellens, Ranie
Haeck, Wanda
Klaassen, Hugo
Bourin, Arnaud
De Clercq, Dries
Allasia, Sara
Boland, Sandro
Marchand, Arnaud
Chaltin, Patrick
Bollen, Mathieu
CANCER RESEARCH, 2021, 81 (13)

← 1 2 3 4 5 →